Table 3:
Median duration of symptoms
| Symptom | Group; duration of symptoms, d, median (IQR) | Difference | p value* | |
|---|---|---|---|---|
| Prednisolone | Placebo | |||
| Facial pain or pressure | 4.5 (2–8) | 5 (2–9) | 0.5 | 0.8 |
| Nasal congestion | 4 (2–7) | 4 (2–9) | 0 | 0.8 |
| Postnasal discharge | 3.5 (1–8) | 3 (1–8) | −0.5 | 0.7 |
| Runny nose | 2 (2–4) | 1 (1–8) | 1 | 0.5 |
| Cough | 2 (1–5) | 3 (1–8) | 1 | 0.046 |
| Total symptoms† | 7 (4–≥ 14) | 9 (6–≥ 14) | 2 | 0.2 |
| 4 of 5 total symptoms | 5 (3–8) | 6 (3–11) | 1 | 0.1 |
| 3 of 5 total symptoms | 3 (2–5) | 4 (2–7) | 1 | 0.2 |
Note: IQR = interquartile range.
*
Mann–Whitney U test.
†
Complete symptom relief of runny nose, postnasal discharge, nasal congestion, cough and facial pain or pressure.